Vical
Biopharmaceutical products based on its patented dna delivery technologies.
San Diego California (HQ)
Financials
Estimates*
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | 13.0m | - | 7.0m | 2.0m | - | 6.0m |
| % growth | - | - | - | (71 %) | - | - |
| EBITDA | - | (8.0m) | (24.0m) | - | - | - |
| % EBITDA margin | - | - | (343 %) | - | - | - |
| Profit | (13.0m) | (9.0m) | (23.0m) | (18.0m) | (27.0m) | (22.0m) |
| % profit margin | (100 %) | - | (329 %) | (900 %) | - | (367 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.5m | Early VC | ||
N/A | - | ||
| N/A | N/A | IPO | |
* | N/A | $33.8m | Post IPO Equity |
* | N/A | $50.0m | Post IPO Equity |
* | N/A | $25.0m | Post IPO Equity |
| Total Funding | $2.5m | ||
Related Content
Recent News about Vical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.